Search Results

20 results

  1. CROM Symposium, Online, 2020, CROM 01

    A consortium approach for consumer-reported outcome measures for assessing tobacco and nicotine-containing products

    ACQUADRO C.(1); AFOLALU E.F.(2); BLACK R.A.(3); CAHOURS X.(4); CHREA C.(2); CLERC E.(2); CURTIN G.(5); EVANS S.(6); GILES L.(7); MacCAFFREY S.(3); PARK H.(8); PRASAD K.(9); SARKAR M.(10); SHIFFMAN S.(11); WEI Lay(10)
    (1) ICON PLC, Lyon, France; (2) Philip Morris Products SA, Switzerland; (3) JUUL Labs, Inc., USA; (4) Imperial Brands, France; (5) RAI Services Company, USA; (6) Turning Point Brands, USA; (7) JT International SA, Switzerland; (8) KT&G Research Institute, Republic of Korea; (9) British American Tobacco, U.K.; (10) Altria Client Services, USA; (11) Pinney Associates, USA
    The continuum of risk of tobacco products is generally accepted among public health authorities, where combustible products like cigarettes are the most risky and noncombustible products are at the lower end of the continuum. Adult smokers (AS)...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 12

    Review of current methodologies in evaluating abuse liability of nicotine and tobacco products in the U.S. regulatory environment

    EVANS S.(1); KONG M.C.(2); CAMPBELL L.(2); SHERWOOD N.(3); PRASAD K.(4)
    (1) Turning Point Brands, Louisville, KY, U.S.A.; (2) Altasciences Clinical Research, Laval, Canada; (3) Neil Sherwood Consulting, Nyon, Switzerland; (4) British American Tobacco, R&D, Millbrook, Southampton, U.K.
    Traditional definitions of abuse and misuse do not apply to a consumer product such as tobacco that consumers essentially use ‘as intended’. In contrast to pharmaceutical products, a guidance for abuse liability testing of nicotine and tobacco...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 44

    Lung biomarkers of harm/effect for tobacco regulatory research: opportunities and challenges – a literature review

    MAKENA P.(1); EDMISTON J.(2); BEATTIE E.(3); MASON E.(4); McEWAN M.(5); PRASAD K.(5)
    (1) RAI Services Company, Winston-Salem, NC, U.S.A.; (2) Altria Client Services LLC, Richmond, VA, U.S.A.; (3) Cliantha Research Limited, Canada; (4) Imperial Brands PLC, Bristol, U.K.; (5) British American Tobacco (Investments) Limited, Southampton, U.K.
    Biomarkers of potential harm (BoPH) are indicators of biological perturbations in response to smoking, which may contribute to smoking-related disease. In this review, a project of the CORESTA Biomarkers Sub-Group, we critically assessed the...
  4. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 28

    Measurement of puffing topography and mouth level exposure: Japan

    PRASAD K.; GEE J.; SLAYFORD S.; GRAY A.; NOTHER K.; CUNNINGHAM A.; MAVROPOULOU E.; PROCTOR C.J.
    British American Tobacco (Investments) Limited, Group R&D, Southampton, U.K.
    Background: BAT has developed the Tobacco Heating Product THP (1.0) which comprises an electrical heating device (glo™ device) and consumable tobacco rods (Neostiks™). A use behaviour study was conducted to demonstrate that consumers use this product...
  5. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 54

    A cross-sectional survey to assess tobacco and nicotine product use behaviour in Japan

    ADAMSON J.; PRASAD K.; CAMACHO O.M.; MURPHY J.
    British American Tobacco (Investments) Limited, R&D, Southampton, U.K.
    The rapid emergence of next generation products (NGPs), with their potential to reduce exposure to harmful substances, has substantially changed the tobacco and nicotine landscape in recent years. The impact of introducing NGPs on individuals and the...
  6. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, ST 64

    What fundamental tobacco science teaches us about heated tobacco products – assessment on THP1.0

    EATON D.; JAKAJ B.; FORSTER M.; LIU Chuan; PRASAD K.
    British American Tobacco (Investments) Limited, R&D, Southampton, U.K.
    Heated tobacco products are designed to reduce toxicant emissions in aerosol as compared to cigarette smoke. Different heating mechanisms have been used in this type of product, either using solid fuels (e.g. charcoal) or electrical energy (e.g....
  7. CORESTA Congress, Kunming, 2018, Smoke Science/Product Technology Groups, STPOST 50

    A risk-based approach for the validation of bespoke smoking analyser software

    JONES J.; PRASAD K.; SLAYFORD S.; GRAY A.; MACRAE C.; THOMPSON C.
    British American Tobacco (Investments) Limited, Group R&D, Southampton, U.K.
    Background: The Smoking Analyser 7 (SA7), a device for measuring consumer’s puffing topography and mouth-level exposure, has been used extensively by British American Tobacco (BAT) since 1999. Due to the ever-changing nature of technology and the...
  8. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, STPOST 34

    Optical method for estimating mouth level exposure from conventional cigarettes and next generation tobacco and nicotine products

    PRASAD K.; SLAYFORD S.; ASHLEY M.; GEE J.; NOTHER K.; GRAY A.; JONES J.
    British American Tobacco (Investments) Limited, Central R&D, Southampton, U.K.
    Novel tobacco and nicotine products like the emerging devices that heat tobacco instead of burning it (THPs) and electronic nicotine delivery systems (ENDS), generate significantly fewer and lower amounts of toxicants compared with conventional...
  9. TSRC, Tob. Sci. Res. Conf., 2016, 70, abstr. 60

    A proposed bridging approach for the assessment of novel tobacco products

    FEARON I.M.; MURPHY J.J.; GAҪA M.D.; CAMACHO O.M.; PRASAD K.; PROCTOR C.
    British American Tobacco (Investments) Limited, Southampton, UK
    Novel tobacco and nicotine products, including e-cigarettes and heated tobacco products, have rapidly increased in popularity over the last 5 years and this has mainly been driven by rapid innovation with new products and e-liquids introduced to the...